Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined with Phototherapy in Advanced Stage Mycosis Fungoides

Christina J. Walker; Maria L. Espinosa; Neha Mehta-Shah; Barbara Pro; Joan Guitart; Timothy Kuzel

doi:10.36849/JDD.5756

Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined with Phototherapy in Advanced Stage Mycosis Fungoides

Christina J. Walker
, Maria L. Espinosa
, Neha Mehta-Shah
, Barbara Pro
, Joan Guitart
, Timothy Kuzel

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Abstract

The combination of Interferon-α-2b (IFN-α-2b) and phototherapy is highly effective in treating mycosis fungoides (MF) but side effects often lead to discontinuation of therapy.1.

Original language	English
Pages (from-to)	349-350
Number of pages	2
Journal	Journal of Drugs in Dermatology
Volume	20
Issue number	3
DOIs	https://doi.org/10.36849/JDD.5756
State	Published - Mar 2021

Access to Document

10.36849/JDD.5756

Cite this

@article{3691cc0a9190402c9c2081c3d3cf3b39,

title = "Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined with Phototherapy in Advanced Stage Mycosis Fungoides",

abstract = "The combination of Interferon-\α-2b (IFN-\α-2b) and phototherapy is highly effective in treating mycosis fungoides (MF) but side effects often lead to discontinuation of therapy.1.",

author = "Walker, \{Christina J.\} and Espinosa, \{Maria L.\} and Neha Mehta-Shah and Barbara Pro and Joan Guitart and Timothy Kuzel",

note = "Funding Information: Funding: Partially funded by Schering-Plough.",

year = "2021",

month = mar,

doi = "10.36849/JDD.5756",

language = "English",

volume = "20",

pages = "349--350",

journal = "Journal of Drugs in Dermatology",

issn = "1545-9616",

number = "3",

}

TY - JOUR

T1 - Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined with Phototherapy in Advanced Stage Mycosis Fungoides

AU - Walker, Christina J.

AU - Espinosa, Maria L.

AU - Mehta-Shah, Neha

AU - Pro, Barbara

AU - Guitart, Joan

AU - Kuzel, Timothy

N1 - Funding Information: Funding: Partially funded by Schering-Plough.

PY - 2021/3

Y1 - 2021/3

N2 - The combination of Interferon-α-2b (IFN-α-2b) and phototherapy is highly effective in treating mycosis fungoides (MF) but side effects often lead to discontinuation of therapy.1.

AB - The combination of Interferon-α-2b (IFN-α-2b) and phototherapy is highly effective in treating mycosis fungoides (MF) but side effects often lead to discontinuation of therapy.1.

UR - https://www.scopus.com/pages/publications/85102689438

U2 - 10.36849/JDD.5756

DO - 10.36849/JDD.5756

M3 - Letter

C2 - 33683074

AN - SCOPUS:85102689438

SN - 1545-9616

VL - 20

SP - 349

EP - 350

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

IS - 3

ER -

Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined with Phototherapy in Advanced Stage Mycosis Fungoides

Abstract

Access to Document

Other files and links

Fingerprint

Cite this